HIV-1 Vif, APOBEC, and Intrinsic Immunity
2008

HIV-1 Vif, APOBEC, and Intrinsic Immunity

publication Evidence: high

Author Information

Author(s): Goila-Gaur Ritu, Strebel Klaus

Primary Institution: National Institute of Allergy and Infectious Diseases, National Institutes of Health

Hypothesis

How does HIV-1 Vif interact with APOBEC proteins to evade the host's intrinsic immunity?

Conclusion

HIV-1 Vif effectively inhibits the antiviral activity of APOBEC proteins, particularly APOBEC3G, through both degradation-dependent and degradation-independent mechanisms.

Supporting Evidence

  • HIV-1 Vif is crucial for the production of infectious virus.
  • APOBEC proteins can inhibit HIV-1 replication through deaminase activity.
  • Vif prevents the encapsidation of APOBEC proteins into viral particles.

Takeaway

HIV-1 has a special protein called Vif that helps it avoid being attacked by the body's defenses, specifically a group of proteins called APOBEC that usually help fight off viruses.

Methodology

This review summarizes current knowledge on the interaction between HIV-1 Vif and APOBEC proteins, focusing on their mechanisms of action.

Limitations

The review does not provide new experimental data but synthesizes existing literature.

Digital Object Identifier (DOI)

10.1186/1742-4690-5-51

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication